Sato Pharmaceutical Co., Ltd. has obtained marketing and manufacturing approval for the oral antifungal agent, Nailin ca...
Telix Pharmaceuticals , an Australian biopharmaceutical company focused on the development of diagnostic and therapeutic...
Storm Therapeutics, a Cambridge Life Sciences firm has attracted an additional £4m cash injection to its £12...
Takeda Pharmaceutical is planning to acquire Belgian biopharmaceutical venture TiGenix with an aim of strengthening...
Alexion Pharmaceuticals, recently bagged approval for its key candidate Soliris (eculizumab) fromthe Ministry of Health,...
A group of researchers at Osaka University, Japan have refined the method of making bio-ink droplets stick to each other...
US based X-Chem, Inc. and Otsuka Pharmaceutical Co., Ltd., a subsidiary of Otsuka Holdings Co., Ltd. headquartered in To...
Scientists at Tohoku University in Japan have created a database of metabolites from blood samples collected from over 5...
Israel based Yozma Group is planning to invest in Japanese startups in the coming year, targeting companies in medicine,...
The Kenyan government has collaborated with the government of Japan and launched a health development program that seeks...
Toshio Fujimoto, MD, MBA has been appointed General Manager of the Health Innovation Park in Shonan, by Takeda Pharmaceu...
Toshiba Medical Systems Corporation has launched its new computed tomography (CT) system, Aquilion Prime SP, to provide ...
A group of researchers from Kyoto University’s Institute for Integrated Cell-Material Science (iCeMS), in collabor...
Japan’s Mitsubishi Tanabe Pharma America, Inc. today announced that more than 1,000 people with amyotrophic latera...
The health ministry in Japan is planning to expand the range of hospitals that can impose additional fees on patients wi...
The member company of K-ICT Born2Global Centre, WELT, has developed the world's first smart belt, designed to assist use...
Shimadzu, an analytical instrument manufacturer, has announced the formation of a partnership with Cure Pharmaceutical G...
Japan based Sumitomo Dainippon Pharma is adding a phase III drug Imeglimin to its growing diabetes product pipeline in a...
